Background Accumulating evidence suggests a beneficial effective of tumour necrosis factor‐
alpha (TNF‐α) inhibitors on the outcomes of COVID‐19 disease, which, however is not …

Objectives This study aimed to conduct a comprehensive systematic literature review and
meta-analysis to assess the risk and outcomes of coronavirus disease 2019 (COVID-19) in …

Objective Some patients with rheumatic diseases might be at higher risk for coronavirus
disease 2019 (COVID‐19) acute respiratory distress syndrome (ARDS). We aimed to …

Objectives The objective of the current study was to evaluate the severity of COVID-19 and
identify factors associated with severe disease outcomes in patients with spondyloarthritis …

COVID-19 has proven to be particularly serious and life-threatening for patients presenting
with pre-existing pathologies. Patients affected by rheumatic musculoskeletal disease …

Background: The economic burden of rheumatoid arthritis (RA) and ankylosing spondylitis
(AS) in India is significant. Aim: To estimate the cost of illness (COI) and out-of-pocket …

The COVID‐19 pandemic emphasized the utility of subcutaneous (SC) biologics for
pressured healthcare systems. The first SC form of infliximab, CT‐P13 SC, provided safe …

Abstract Durch das COVID-19-Register (www. covid19-rheuma. de) der Deutschen
Gesellschaft für Rheumatologie erfolgte erstmalig die Erfassung und systematische …

Spondyloarthritis is an umbrella term for a group of inflammatory diseases of the joints and
spine. The group includes ankylosing spondylitis, reactive arthritis, psoriatic arthritis, arthritis …

Objective. Some patients with rheumatic diseases might be at higher risk for coronavirus
disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS). We aimed to …